AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Driven Dissection News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Driven Dissection. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Driven Dissection Today - Breaking & Trending Today
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021
ABBVie today announced the presentation of new data on RINVOQ ® SKYRIZI ® and HUMIRA ® across multiple rheumatic diseases at the American College of Rheumatology's annual meeting to be held virtually Nov. 3-9 . A total of 38 abstracts, including two oral presentations and one plenary session presentation, will be presented from a broad range of studies in rheumatoid arthritis, psoriatic arthritis and ankylosing ...
Source: investingnews.com
AbbVie Highlights Innovative Research From Its Rheumatology Portfolio at ACR Convergence 2021
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab)...
Source: prnewswire.com